Headline Roundup • October 4th, 2025
FDA Approves New Generic Version of Abortion Pill Mifepristone, Drawing GOP Criticism
Summary from the AllSides News Team
The Food and Drug Administration approved a new generic version of the abortion pill mifepristone, made by drugmaker Evita Solutions. The federal agency cleared the low-cost version, which can be used to end pregnancies up to 10 weeks, Evita Solutions announced on its website.
The Details: The latest approval drew criticism from anti-abortion groups and some Republican lawmakers, who questioned the FDA’s handling of mifepristone and called for stricter rules on how the pill is prescribed and dispensed. Approving a generic version is normally a routine process. The agency mainly checks that the generic drug matches the original. But because mifepristone is used to end pregnancies, the decision continues to draw political attention.
For Context: Mifepristone was first approved in 2000 and has become more accessible over time. The FDA authorized the first generic version, made by GenBioPro, in 2019. In 2021, the agency allowed telehealth prescribing and mail delivery of the drug during the Biden administration, expanding access nationwide.
Key Quotes: “This Administration will ensure that women’s health is properly protected by thoroughly investigating the circumstances under which mifepristone can be safely dispensed,” Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary wrote in a Sept. 19 letter.
How The Media Covered It: Newsmax (Right bias) portrayed the FDA’s approval of Evita Solutions’ generic mifepristone as “a moral failure” and “federal overreach,” while highlighting backlash from conservatives. The Hill (Center) focused on political fallout, framing the FDA’s approval as a test of the Trump administration’s stance on abortion rather than a scientific issue. NBC News (Lean Left) focused on the FDA’s process and scientific background while highlighting that medication abortion is “safe, effective, and essential health care.”
Written by the AllSides staff (of humans). Learn more. Support our mission.
Featured Coverage of this Story
Sarah Silbiger/Getty Images file
The anti-abortion movement’s patience with the Food and Drug Administration (FDA) is wearing thin following the agency’s recent approval of a second generic version of mifepristone, one of two drugs taken for a medication abortion.
President Trump repeatedly pledged during the campaign last year that he would leave abortion policy to the states, but anti-abortion advocates and lawmakers have been pushing him to go further and sharply restrict the availability of mifepristone.
The Food and Drug Administration on Tuesday quietly approved a generic form of mifepristone, one of the two medications used in most U.S. abortions.
That makes the drug, from the company Evita Solutions, the second generic version to hit the market. The first, from pharmaceutical company GenBioPro, was approved in 2019.
The U.S. Food and Drug Administration has approved Evita solution's generic version of the abortion drug, mifepristone, the regulator said.
The drug is manufactured by privately-held company that describes its mission as being to "normalize abortion" and make it "accessible to all," the FDA said in a letter dated September 30.
AllSides Picks
.png)
More News about Healthcare on AllSides
News from the Left
News from the Center
News from the Right
Just The News
